INNOVATIVE Contact Lens for Dry Eye Treatment - CyteSolutions Lens
Born out of the frustration of taking multiple eye drops, multiple times per day, Pitt engineering grad student researcher Alexis Nolfi along with Vishal Jhanji of the School of Medicine, are developing a new technology in contact lenses. I first saw this article in InVision magazine and thought I would share it with you all, as I found it interesting.
These two are working to develop a new therapy tool and drug delivery system to target inflammation, which is the leading cause of dry eyes. The CyteSolutions Lens is a silicone hydrogel-based contact lenses coated with natural biopolymers containing a drug that targets inflammatory dry eye pathways not targeted by any current treatments.
It is activated when it makes contact with enzymes that are in your eye. This allows a slow release of the drug to reduce inflammation. The big difference between this and previously developed contact lenses is that the biopolymers will allow for a longer release vs old models that just bathed the contact lens in the drug continually.
This technology looks very promising but is still years away from being released into the market, as it hasn’t started clinical trials.
What are my thoughts and what does this mean for you?
This is exciting new technology in the dry eye treatment space, but it is still pretty far from being introduced into the market. It tackles inflammation, which is at the core of most dry eye.
The only problem I have is that this is still not addressing the CAUSE of inflammation and just attacking the inflammation itself. This will be helpful for people, but we need to first battle the inflammation by having a great eyelid hygiene routine (click here to see Dr. Jenna Zigler’s), and then focusing on the foods we put in our body to decrease overall systemic inflammation in disease.